ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
ResMed's total debt was $259.95M at Jun 30, 2026. For fiscal 2026 it was $259.95M, up 2525.8% from the year before. Over ten years it grew -14.0% a year on average. The highest annual figure on record is $1.17B in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $259.95M | +2525.8% |
| FY2025 | Jun 30, 2025 | $9.90M | 0.0% |
| FY2024 | Jun 30, 2024 | $9.90M | -0.0% |
| FY2023 | Jun 30, 2023 | $9.90M | -0.1% |
| FY2022 | Jun 30, 2022 | $9.92M | -17.4% |
| FY2021 | Jun 30, 2021 | $12.00M | +0.1% |
| FY2020 | Jun 30, 2020 | $11.99M | -0.0% |
| FY2019 | Jun 30, 2019 | $11.99M | +4.6% |
| FY2018 | Jun 30, 2018 | $11.47M | -98.9% |
| FY2017 | Jun 30, 2017 | $1.08B | -8.0% |
| FY2016 | Jun 30, 2016 | $1.17B | +290.2% |
| FY2015 | Jun 30, 2015 | $300.59M | -0.1% |
| FY2014 | Jun 30, 2014 | $300.79M | +0.0% |
| FY2013 | Jun 30, 2013 | $300.79M | +19.9% |
| FY2012 | Jun 30, 2012 | $250.84M | +150.4% |
| FY2011 | Jun 30, 2011 | $100.16M | -17.7% |
| FY2010 | Jun 30, 2010 | $121.69M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $259.95M | +2525.8% |
| Q3 FY2026 | Mar 31, 2026 | $259.93M | +2523.9% |
| Q2 FY2026 | Dec 31, 2025 | $259.91M | +2523.7% |
| Q1 FY2026 | Sep 30, 2025 | $259.90M | +2526.3% |
| Q4 FY2025 | Jun 30, 2025 | $9.90M | 0.0% |
| Q3 FY2025 | Mar 31, 2025 | $9.91M | +0.0% |
| Q2 FY2025 | Dec 31, 2024 | $9.91M | +0.1% |
| Q1 FY2025 | Sep 30, 2024 | $9.90M | -0.1% |
| Q4 FY2024 | Jun 30, 2024 | $9.90M | -0.0% |
| Q3 FY2024 | Mar 31, 2024 | $9.90M | +0.0% |
| Q2 FY2024 | Dec 31, 2023 | $9.90M | -0.0% |
| Q1 FY2024 | Sep 30, 2023 | $9.91M | -0.0% |
| Q4 FY2023 | Jun 30, 2023 | $9.90M | -0.1% |
| Q3 FY2023 | Mar 31, 2023 | $9.90M | -17.3% |
| Q2 FY2023 | Dec 31, 2022 | $9.90M | -17.5% |
| Q1 FY2023 | Sep 30, 2022 | $9.91M | -17.4% |
| Q4 FY2022 | Jun 30, 2022 | $9.92M | -17.4% |
| Q3 FY2022 | Mar 31, 2022 | $11.97M | -0.2% |
| Q2 FY2022 | Dec 31, 2021 | $12.00M | +0.1% |
| Q1 FY2022 | Sep 30, 2021 | $12.00M | +0.1% |
| Q4 FY2021 | Jun 30, 2021 | $12.00M | +0.1% |
| Q3 FY2021 | Mar 31, 2021 | $11.99M | +0.0% |
| Q2 FY2021 | Dec 31, 2020 | $11.99M | +0.0% |
| Q1 FY2021 | Sep 30, 2020 | $11.99M | -0.0% |
| Q4 FY2020 | Jun 30, 2020 | $11.99M | -0.0% |
| Q3 FY2020 | Mar 31, 2020 | $11.99M | -2.9% |
| Q2 FY2020 | Dec 31, 2019 | $11.98M | +0.1% |
| Q1 FY2020 | Sep 30, 2019 | $11.99M | +0.1% |
| Q4 FY2019 | Jun 30, 2019 | $11.99M | +4.6% |
| Q3 FY2019 | Mar 31, 2019 | $12.35M | -98.8% |
| Q2 FY2019 | Dec 31, 2018 | $11.98M | -98.8% |
| Q1 FY2019 | Sep 30, 2018 | $11.98M | -98.9% |
| Q4 FY2018 | Jun 30, 2018 | $11.47M | -99.0% |
| Q2 FY2018 | Dec 31, 2017 | $1.02B | -12.8% |
| Q1 FY2018 | Sep 30, 2017 | $1.02B | -13.1% |
| Q4 FY2017 | Jun 30, 2017 | $1.08B | – |
| Q3 FY2017 | Mar 31, 2017 | $1.17B | – |
| Q2 FY2017 | Dec 31, 2016 | $1.17B | – |
| Q1 FY2017 | Sep 30, 2016 | $1.17B | – |